Successful treatment of metastatic choriocarcinoma after DMP 840.

PubWeight™: 1.04‹?› | Rank: Top 15%

🔗 View Article (PMID 21224112)

Published in Urol Oncol on January 12, 2011

Authors

C B Pratt1, B N Rao, C F Stewart, J J Jenkins

Author Affiliations

1: Department of Hematology/Oncology, St. Jude Children's Research Hospital, USA; Departments of Pediatrics, Surgery, Pharmacy and Pathology, University of Tennessee Memphis, College of Medicine, Memphis, Tennessee, USA.

Articles citing this

Phase I study of DMP 840 in pediatric patients with refractory solid tumors. Invest New Drugs (1998) 0.75

Articles by these authors

The role of inherited TPMT and COMT genetic variation in cisplatin-induced ototoxicity in children with cancer. Clin Pharmacol Ther (2013) 2.40

Low-grade astrocytoma: a decade of experience at St. Jude Children's Research Hospital. J Clin Oncol (1997) 1.94

Alveolar soft part sarcoma in children and adolescents: clinical features and outcome of 11 patients. Med Pediatr Oncol (1996) 1.85

War Experiences with the Nonsuture Technic of Anastomosis in Primary Arterial Injuries. Ann Surg (1947) 1.84

Relationship between topotecan systemic exposure and tumor response in human neuroblastoma xenografts. J Natl Cancer Inst (1998) 1.82

Dynamic specification of coarticulated vowels. J Acoust Soc Am (1983) 1.69

Clinical manifestations of ganglioneuroma. Cancer (1989) 1.66

Prevalence and distribution of high-risk human papilloma virus (HPV) types in invasive squamous cell carcinoma of the cervix and in normal women in Andhra Pradesh, India. BMC Infect Dis (2005) 1.65

Concordance of DMET plus genotyping results with those of orthogonal genotyping methods. Clin Pharmacol Ther (2012) 1.62

Preirradiation chemotherapy with carboplatin and etoposide in newly diagnosed embryonal pediatric CNS tumors. J Clin Oncol (1995) 1.58

Relation between 9-aminocamptothecin systemic exposure and tumor response in human solid tumor xenografts. Clin Cancer Res (2001) 1.56

Local tumor control in rhabdomyosarcoma following low-dose irradiation: comparison of group II and select group III patients. Int J Radiat Oncol Biol Phys (1995) 1.51

Synergy of topotecan in combination with vincristine for treatment of pediatric solid tumor xenografts. Clin Cancer Res (1999) 1.47

Identification of vowels in "vowelless" syllables. Percept Psychophys (1983) 1.45

Direct translation of a protracted irinotecan schedule from a xenograft model to a phase I trial in children. J Clin Oncol (1999) 1.41

Etoposide: an update. Clin Pharm (1989) 1.41

Wilms' tumor: reduced-dose radiotherapy in advanced-stage Wilms' tumor with favorable histology. Int J Radiat Oncol Biol Phys (1990) 1.38

A young woman with lymphoma and endocarditis. Lancet (1995) 1.38

Bone sarcomas of the head and neck in children: the St Jude Children's Research Hospital experience. Cancer (2000) 1.37

Colon carcinoma in children and adolescents. A review of 30 cases. Cancer (1985) 1.36

Biochemical correlates of temozolomide sensitivity in pediatric solid tumor xenograft models. Clin Cancer Res (2000) 1.35

Botulinum toxin management of spasmodic dysphonia (laryngeal dystonia): a 12-year experience in more than 900 patients. Laryngoscope (1998) 1.32

Anatomic variations in the tetralogy of Fallot. Am Heart J (1971) 1.28

Antitumor activity of temozolomide combined with irinotecan is partly independent of O6-methylguanine-DNA methyltransferase and mismatch repair phenotypes in xenograft models. Clin Cancer Res (2000) 1.27

Evaluation of 9-dimethylaminomethyl-10-hydroxycamptothecin against xenografts derived from adult and childhood solid tumors. Cancer Chemother Pharmacol (1992) 1.24

Metastases detected at the time of diagnosis of primary pediatric extremity osteosarcoma at diagnosis: imaging features. Cancer (1999) 1.22

High-dose chemotherapy and autologous bone marrow rescue followed by interstitial and external-beam radiotherapy in newly diagnosed pediatric malignant gliomas. J Clin Oncol (1993) 1.19

Phase I trial and pharmacokinetic (PK) and pharmacodynamics (PD) study of topotecan using a five-day course in children with refractory solid tumors: a pediatric oncology group study. J Pediatr Hematol Oncol (1996) 1.18

A prospective study of Hickman/Broviac catheters and implantable ports in pediatric oncology patients. J Clin Oncol (1989) 1.17

Identification of an E-selectin region critical for carbohydrate recognition and cell adhesion. J Cell Biol (1992) 1.16

Sarcomas (other than Ewing's) of flat bones in children and adolescents. A clinicopathologic study. Cancer (1990) 1.15

Inhibition of the interferon-gamma/signal transducers and activators of transcription (STAT) pathway by hypermethylation at a STAT-binding site in the p21WAF1 promoter region. Cancer Res (2000) 1.15

Carboplatin/ifosfamide window therapy for osteosarcoma: results of the St Jude Children's Research Hospital OS-91 trial. J Clin Oncol (2001) 1.15

Neonatal alveolar rhabdomyosarcoma with skin and brain metastases. Cancer (2001) 1.14

Activation of CPT-11 in mice: identification and analysis of a highly effective plasma esterase. Cancer Res (2000) 1.12

Cutaneous and subcutaneous Ewing's sarcoma: an indolent disease. Int J Radiat Oncol Biol Phys (2000) 1.11

Cerebrospinal fluid pharmacokinetics and penetration of continuous infusion topotecan in children with central nervous system tumors. Cancer Chemother Pharmacol (1996) 1.10

Methotrexate systemic clearance influences probability of relapse in children with standard-risk acute lymphocytic leukaemia. Lancet (1984) 1.10

Unusual cutaneous toxicity following treatment with dactinomycin: a report of two cases. Med Pediatr Oncol (1995) 1.09

Low-grade astrocytoma with neuraxis dissemination at diagnosis. J Neurosurg (1995) 1.09

Prognostic factors for local and distant control in Ewing sarcoma family of tumors. Ann Oncol (2007) 1.08

Accuracy of MR imaging for detecting epiphyseal extension of osteosarcoma. Pediatr Radiol (2000) 1.08

Prognostic factors for children and adolescents with surgically resected nonrhabdomyosarcoma soft tissue sarcoma: an analysis of 121 patients treated at St Jude Children's Research Hospital. J Clin Oncol (1999) 1.06

Improved prognosis of children with osteosarcoma metastatic to the lung(s) at the time of diagnosis. Cancer (1992) 1.06

SV40 DNA in human osteosarcomas shows sequence variation among T-antigen genes. Int J Cancer (1997) 1.05

Medulloblastoma in very young children: outcome of definitive craniospinal irradiation following incomplete response to chemotherapy. J Clin Oncol (1994) 1.04

Efficacy of systemic administration of irinotecan against neuroblastoma xenografts. Clin Cancer Res (1997) 1.04

Brain metastases in children with melanoma. Cancer (1997) 1.03

Bithalamic involvement predicts poor outcome among children with thalamic glial tumors. Pediatr Neurosurg (1998) 1.03

Synovial sarcoma in children and adolescents: the St Jude Children's Research Hospital experience. J Clin Oncol (1994) 1.02

Comparison by 1H-nmr spectroscopy of the conformation of the 2600 dalton antifreeze glycopeptide of polar cod with that of the high molecular weight antifreeze glycoprotein. Biopolymers (1987) 1.02

Second malignant neoplasms occuring in survivors of osteosarcoma. Cancer (1997) 1.02

Abnormal odontogenesis in children treated with radiation and chemotherapy: imaging findings. AJR Am J Roentgenol (1994) 1.02

Pediatric choroid plexus neoplasms. Int J Radiat Oncol Biol Phys (1999) 1.02

Supratentorial malignant gliomas in childhood: a single institution perspective. Cancer (1997) 1.01

Characterization of the oligosaccharide alditols from ovarian cyst mucin glycoproteins of blood group A using high pressure liquid chromatography (HPLC) and high field 1H NMR spectroscopy. J Biol Chem (1986) 1.01

Comparison of CSF cytology and spinal magnetic resonance imaging in the detection of leptomeningeal disease in pediatric medulloblastoma or primitive neuroectodermal tumor. J Clin Oncol (1999) 1.01

Breast malignancy in children. J Pediatr Surg (1994) 1.00

Phase I study of topotecan in combination with cyclophosphamide in pediatric patients with malignant solid tumors: a Pediatric Oncology Group Study. J Clin Oncol (1998) 0.99

Role of adjuvant chemotherapy in the treatment of surgically resected pediatric nonrhabdomyosarcomatous soft tissue sarcomas: A Pediatric Oncology Group Study. J Clin Oncol (1999) 0.98

Late effects of treatment for germ cell tumors during childhood and adolescence. J Pediatr Hematol Oncol (1999) 0.98

Clinical value of proton magnetic resonance spectroscopy for differentiating recurrent or residual brain tumor from delayed cerebral necrosis. Int J Radiat Oncol Biol Phys (1996) 0.97

Feasibility and efficacy of preirradiation chemotherapy for pediatric brain tumors. Neurosurgery (1988) 0.97

Treatment of children with peripheral primitive neuroectodermal tumor or extraosseous Ewing's tumor with Ewing's-directed therapy. J Pediatr Hematol Oncol (1998) 0.97

Topotecan for the treatment of recurrent or progressive central nervous system tumors - a pediatric oncology group phase II study. J Neurooncol (1999) 0.96

Clinical use of topoisomerase I inhibitors in anticancer treatment. Med Pediatr Oncol (2000) 0.96

Multiple genomic alterations including N-myc amplification in a primary large cell medulloblastoma. Pediatr Neurosurg (2000) 0.95

Brain metastases in pediatric Ewing sarcoma and rhabdomyosarcoma: the St. Jude Children's Research Hospital experience. J Pediatr Hematol Oncol (1999) 0.95

The impact of margin of resection on outcome in pediatric nonrhabdomyosarcoma soft tissue sarcoma. J Pediatr Surg (1999) 0.95

Treatment of unresectable or metastatic pediatric soft tissue sarcomas with surgery, irradiation, and chemotherapy: a Pediatric Oncology Group study. Med Pediatr Oncol (1998) 0.95

Effective schedules of exposure of medulloblastoma and rhabdomyosarcoma xenografts to topotecan correlate with in vitro assays. Clin Cancer Res (1998) 0.94

Imaging findings of hemorrhagic cystitis in pediatric oncology patients. Pediatr Radiol (2000) 0.94

Prognostic factors and imaging patterns of recurrent pulmonary nodules after thoracotomy in children with osteosarcoma. Cancer (2001) 0.94

Malignant peripheral nerve sheath tumors: the St. Jude Children's Research Hospital experience. Ann Surg Oncol (1995) 0.93

The impact of delayed surgery on radiotherapy dose and local control of rhabdomyosarcoma. Arch Surg (1987) 0.93

Conformations of blood group H-active oligosaccharides of ovarian cyst mucins. Biopolymers (1985) 0.93

Medulloblastoma with brain stem involvement: the impact of gross total resection on outcome. Pediatr Neurosurg (1996) 0.93

Treatment of childhood germ cell tumors. Review of the St. Jude experience from 1979 to 1988. Cancer (1992) 0.92

Epithelioid sarcoma: clinical, MR imaging and pathologic findings. Skeletal Radiol (2002) 0.92

Extrarenal Wilms' tumor. J Pediatr Surg (1989) 0.92

Nonrhabdomyosarcomatous soft tissue sarcomas of childhood: formulation of a simplified system for grading. Mod Pathol (1995) 0.92

Long-term results with radiation therapy for pediatric desmoid tumors. Int J Radiat Oncol Biol Phys (2000) 0.92

Primary cutaneous phaeohyphomycosis due to Exserohilum rostratum (Drechslera rostrata) in a child with leukemia. Pediatr Infect Dis (1986) 0.92

Ifosfamide, Fanconi's syndrome, and rickets. J Clin Oncol (1991) 0.92

Ewing's sarcoma: local tumor control and patterns of failure following limited-volume radiation therapy. Int J Radiat Oncol Biol Phys (1991) 0.91

Infradiaphragmatic extralobar pulmonary sequestration masquerading as an intra-abdominal, suprarenal mass. Pediatr Surg Int (1997) 0.91

Malignant evolution of choroid plexus papilloma. Pediatr Neurosurg (1999) 0.90

The use of a closed expandable prosthesis for pediatric sarcomas. Chir Organi Mov (2004) 0.90

Studies of the efficacy and pharmacology of irinotecan against human colon tumor xenograft models. Clin Cancer Res (1998) 0.90

Primary Ewing tumor of the vertebrae: clinical characteristics, prognostic factors, and outcome. Med Pediatr Oncol (2001) 0.90

Efficacy of oral irinotecan against neuroblastoma xenografts. Anticancer Drugs (1997) 0.90

Comparison of lumbar and shunt cerebrospinal fluid specimens for cytologic detection of leptomeningeal disease in pediatric patients with brain tumors. J Clin Oncol (1999) 0.90